Ceftazidime is a third-generation cephalosporin used for the treatment of Gram-negative bacteria only approved for parenteral use by intravenous and intramuscular route. In some clinical situations, off-label subcutaneous injection could be a salvage route for the administration of antibiotics, especially in geriatrics, despite the paucity of evidence about efficacy and safety. We report a case of a successful and well-tolerated subcutaneous ceftazidime therapy in a 90-year-old woman for the treatment of an acute urinary tract infection caused by Pseudomonas aeruginosa with therapeutic drug monitoring data.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/fcp.12520 | DOI Listing |
Publication Analysis
Top Keywords
efficacy safety
8
safety subcutaneous
4
subcutaneous administration
4
administration ceftazidime
4
ceftazidime salvage
4
salvage therapy
4
therapy geriatrics
4
geriatrics case
4
case report
4
report ceftazidime
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!